Tesla: Q1 Consensus Estimates

Tesla (NASDAQ: TSLA) will be reporting their first quarter financial results on April 26th after market close. Analysts have a consensus $650.81 12-month price target on the company, via a total of 38 analysts, with nine analysts having strong buy ratings. Six analysts meanwhile have buy ratings, 12 have hold ratings, seven analysts have a sell rating and four have strong sells on the company. The street high comes from Piper Sandler with a $1,200 price target, and the lowest target sits at $67 from GLJ Research.

21 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 21 analysts is $10.62 billion; this number has been revised upwards from $10.3 billion at the start of the year. The highest revenue estimate is $12.34 billion, while the lowest is $8.2 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $1.8 billion, with this number having been revised down from $2 billion at the start of the year. The street high estimate currently sits at $2 billion in EBITDA and the lowest is $1.2 billion.

Analysts estimate that quarterly earnings per share will come in at $0.85, with this number being slightly revised down from $0.91 at the start of the year. Street high is $0.97 and the lowest estimate is $0.46 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

PI Financial Discontinues Coverage On Medipharm Labs, Heritage Cannabis

Friday evening following the close of markets, a note was sent out by PI Financials...

Monday, September 28, 2020, 07:42:00 AM

Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target

On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative...

Monday, April 19, 2021, 10:36:00 AM

Canaccord Reiterates Rating On CloudMD After Quarterly Results

On August 25, CloudMD Software & Services (TSXV: DOC) reported their second quarter financial results....

Saturday, August 28, 2021, 03:10:00 PM

Kinross: Canaccord Leaves Price Target Unchanged Following Peak Gold Acquisition

Yesterday, Kinross Gold Corp (TSX: L) (NYSE: KGC) announced that they had entered into agreements...

Thursday, October 1, 2020, 03:01:00 PM

Tilray: Cantor Slashes Price Target To $7.40 Ahead Of Earnings

Tilray (TSX: TLRY) is expected to report its second fiscal quarter 2022 results on January...

Friday, January 7, 2022, 03:58:00 PM